A novel versatile flow-donor chamber as biorelevant ex-vivo test assessing oral mucoadhesive formulations.

Ex-vivo release-permeation systems Flow through diffusion cells Intraoral drug delivery Mesoporous silica particles Mucoadhesion Oral transmucosal delivery

Journal

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
ISSN: 1879-0720
Titre abrégé: Eur J Pharm Sci
Pays: Netherlands
ID NLM: 9317982

Informations de publication

Date de publication:
01 Nov 2021
Historique:
received: 28 04 2021
revised: 20 08 2021
accepted: 24 08 2021
pubmed: 31 8 2021
medline: 16 9 2021
entrez: 30 8 2021
Statut: ppublish

Résumé

Oral transmucosal drug delivery is a non-invasive administration route for rapid therapeutic onset and greater bioavailability avoiding the first-pass metabolism. Mucoadhesive formulations are advantageous as they may retain the drug at the administration site. Proper equipment to assess mucoadhesive properties and corresponding drug absorption is fundamental for the development of novel drug delivery systems. Here we developed a new flow-through donor chamber for well-established diffusion cells, and we tested the effects on drug and formulation retention in situ of adding mucoadhesive polymers or mesoporous silica particles to a reference formulation. Mesoporous silica particles are of particular interest as they may be used to encapsulate and retain drug molecules. Compared to other ex-vivo methods described in literature for assessing mucoadhesive performance and transmucosal drug delivery, this new donor chamber provides several advantages: i) it reflects physiological conditions better as a realistic saliva flow can be provided over the administration site, ii) it is versatile since it can be mounted on any kind of vertical diffusion cell allowing simultaneous detection of drug retention at the administration site and drug permeation through the tissue, and iii) it enables optical quantification of formulations residence time aided by image processing. This new flow-through donor diffusion cell set-up proved sensitive to differentiate a reference formulation from one where 20 %(w/w) Carbomer was added (to further improve the mucoadhesive properties), with respect to both drug and formulation residence times. We also found that mesoporous silica particles, investigated as particles only and mixed together with the reference formulation, gave very similar drug and formulation retention to what we observed with the mucoadhesive Carbomer. However, after some time (>30 min) it became obvious that the tablet excipients in the reference formulation promote particle retention on the mucosa. This work provides a new simple and versatile biorelevant test for the evaluation of oral mucoadhesive formulations and paves the way for further studies on mesoporous silica particles as valuable excipients for enhancing oral mucoadhesion.

Identifiants

pubmed: 34461276
pii: S0928-0987(21)00286-4
doi: 10.1016/j.ejps.2021.105983
pii:
doi:

Substances chimiques

Excipients 0
Polymers 0
Tablets 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105983

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Sanna Gidvall (S)

Biomedical Science, Faculty of Health and Society, Malmö University, SE-205 06 Malmö, Sweden; Biofilms - Research Center for Biointerfaces (BRCB), Malmö University, SE-205 06 Malmö, Sweden.

Sebastian Björklund (S)

Biomedical Science, Faculty of Health and Society, Malmö University, SE-205 06 Malmö, Sweden; Biofilms - Research Center for Biointerfaces (BRCB), Malmö University, SE-205 06 Malmö, Sweden.

Adam Feiler (A)

Nanologica AB, SE-151 36 Södertälje, Sweden; Chemistry Department, KTH, Royal Institute of Technology, 100 44 Stockholm, Sweden.

Bengt Dahlström (B)

CTC Clinical Trial Consultants AB, 75237 Uppsala.

Robert Rönn (R)

Orexo AB, 754 50 Uppsala, Sweden.

Johan Engblom (J)

Biomedical Science, Faculty of Health and Society, Malmö University, SE-205 06 Malmö, Sweden; Biofilms - Research Center for Biointerfaces (BRCB), Malmö University, SE-205 06 Malmö, Sweden.

Sabrina Valetti (S)

Biomedical Science, Faculty of Health and Society, Malmö University, SE-205 06 Malmö, Sweden; Biofilms - Research Center for Biointerfaces (BRCB), Malmö University, SE-205 06 Malmö, Sweden. Electronic address: sabrina.valetti@mau.se.

Articles similaires

Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Semiconductors Photosynthesis Polymers Carbon Dioxide Bacteria
Animals Huntington Disease Mitochondria Neurons Mice

Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers.

Prashant Kesharwani, Kratika Halwai, Saurav Kumar Jha et al.
1.00
Chitosan Humans Folic Acid Nanoparticles Drug Carriers

Classifications MeSH